TMEM161A
Transmembrane protein 161A
Also known as: FLJ20422, FLJ39645, T161A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NX61
- Gene
- TMEM161A
- Ensembl
- ENSG00000064545
- Chromosome
- 19
- Canonical length
- 479 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Involved in several processes, including cellular response to UV; regulation of cellular response to stress; and response to retinoic acid. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
479 residues, UniProt reviewed canonical sequence.
>Q9NX61|TMEM161A
1 MAVLGVQLVV TLLTATLMHR LAPHCSFARW LLCNGSLFRY KHPSEEELRA LAGKPRPRGR
61 KERWANGLSE EKPLSVPRDA PFQLETCPLT TVDALVLRFF LEYQWFVDFA VYSGGVYLFT
121 EAYYYMLGPA KETNIAVFWC LLTVTFSIKM FLTVTRLYFS AEEGGERSVC LTFAFLFLLL
181 AMLVQVVREE TLELGLEPGL ASMTQNLEPL LKKQGWDWAL PVAKLAIRVG LAVVGSVLGA
241 FLTFPGLRLA QTHRDALTMS EDRPMLQFLL HTSFLSPLFI LWLWTKPIAR DFLHQPPFGE
301 TRFSLLSDSA FDSGRLWLLV VLCLLRLAVT RPHLQAYLCL AKARVEQLRR EAGRIEAREI
361 QQRVVRVYCY VTVVSLQYLT PLILTLNCTL LLKTLGGYSW GLGPAPLLSP DPSSASAAPI
421 GSGEDEVQQT AARIAGALGG LLTPLFLRGV LAYLIWWTAA CQLLASLFGL YFHQHLAGSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM161A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 30 nTPM
- liver: 16 nTPM
- endometrium: 13 nTPM
- parathyroid gland: 13 nTPM
- adrenal gland: 13 nTPM
- tongue: 12 nTPM
Single-cell type
- myonuclei: 59 nCPM
- decidual stromal cells: 50 nCPM
- retinal pigment epithelial cells: 47 nCPM
- oocytes: 32 nCPM
- hepatocytes: 31 nCPM
- ovarian stromal cells: 31 nCPM
Immune cell
- plasmacytoid DC: 19 nTPM
- T-reg: 11 nTPM
- naive CD4 T-cell: 8.8 nTPM
- myeloid DC: 8.5 nTPM
- gdT-cell: 8.2 nTPM
- memory CD4 T-cell: 7.5 nTPM
Brain region
- choroid plexus: 16 nTPM
- medulla oblongata: 15 nTPM
- white matter: 13 nTPM
- thalamus: 12 nTPM
- pons: 12 nTPM
- cerebral cortex: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- -0.26
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to oxidative stress
- cellular response to UV
- negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage
- positive regulation of DNA repair
- response to retinoic acid
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMEM161A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM161A as an antibody target. Whether an autoantibody or antibody against TMEM161A could matter depends on whether native TMEM161A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM161A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM161A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...